Rowland & CO Investment Counsel Bio Rad Laboratories, Inc. Transaction History
Rowland & CO Investment Counsel
- $455 Million
- Q2 2024
A detailed history of Rowland & CO Investment Counsel transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Rowland & CO Investment Counsel holds 978 shares of BIO stock, worth $325,947. This represents 0.06% of its overall portfolio holdings.
Number of Shares
978
Previous 1,053
7.12%
Holding current value
$325,947
Previous $364,000
26.65%
% of portfolio
0.06%
Previous 0.08%
Shares
16 transactions
Others Institutions Holding BIO
# of Institutions
460Shares Held
19.6MCall Options Held
23.2KPut Options Held
37.4K-
Vanguard Group Inc Valley Forge, PA2.37MShares$791 Million0.01% of portfolio
-
Black Rock Inc. New York, NY1.55MShares$517 Million0.01% of portfolio
-
Veritas Asset Management LLP1.13MShares$376 Million2.63% of portfolio
-
State Street Corp Boston, MA860KShares$287 Million0.01% of portfolio
-
Van Eck Associates Corp659KShares$220 Million0.26% of portfolio
About BIO-RAD LABORATORIES, INC.
- Ticker BIO
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,633,900
- Market Cap $8.21B
- Description
- Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...